Cardiology

Results of PARTNER I trial reported at TCT 2014

New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional status, and resulted in a lower rate of repeat ...

page 39 from 40